Novo Nordisk A/S Class B (NOVOb)

849.0
+6.0(+0.71%)
  • Volume:
    1,072,703
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    841.4 - 850.6

NOVOb Overview

Prev. Close
843
Day's Range
841.4-850.6
Revenue
164.48B
Open
841.7
52 wk Range
604.4-864.4
EPS
23.24
Volume
1,072,703
Market Cap
1.92T
Dividend (Yield)
11.15
(1.31%)
Average Volume (3m)
1,594,764
P/E Ratio
36.97
Beta
0.324
1-Year Change
19.16%
Shares Outstanding
2,260,086,820
Next Earnings Date
31 Jan 2023
What is your sentiment on Novo Nordisk B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B News

Novo Nordisk A/S Class B Analysis

Novo Nordisk A/S Class B Company Profile

Novo Nordisk A/S Class B Company Profile

Employees
52696
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060534915
  • S/N:1742564000

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Read More

Analyst Price Target

Average867.3 (+2.16% Upside)
High1070
Low392
Price849
No. of Analysts28
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsNeutralBuyStrong BuyStrong BuyStrong Buy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy